The increasing frequency of climate-related disasters, including hurricanes, wildfires, and heat waves, highlights the ...
MSD's confidence in its anti-TL1A antibody tulisokibart in inflammatory diseases has been made apparent by a decision to start trials of the drug in three more indications. Already in phase 3 testing ...
AstraZeneca and MSD’s Lynparza has scored its second Phase 3 win in the space of a week, this time in first-line treatment of advanced ovarian cancer. Results from the PAOLA-1 study showed that the ...
Abstract: Intelligent reflecting surface (IRS) is an enabling technology to engineer the radio signal propagation in wireless networks. By smartly tuning the signal reflection via a large number of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback